Reducing unnecessary antibiotic use for children with ear infections
Official title: DISAPEAR Trial: Interventions to De-implement Unnecessary Antibiotic Prescribing for Children With Ear Infections
Run by Intermountain Health Care, Inc. · NCT06034080 · Data updated 2026-11-12
This study is testing two different ways to help doctors give fewer unnecessary antibiotics to kids with ear infections to see which one makes parents happier and follows health guidelines better.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 6 Months to 17 Years |
| Sex | All |
| Enrollment | 1566 (estimated) |
| Sponsor | Intermountain Health Care, Inc. Academic / other |
| Locations | 3 sites (Denver, Colorado and 2 other locations) |
| Status | Recruiting |
| Started | February 3, 2025 |
| Main results expected | June 1, 2027 |
| Study ends | June 2029 |
| Registry record updated | September 3, 2025 |
| Trial ID | NCT06034080 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates for this study are children aged 6 months to 17 years diagnosed with acute otitis media, along with their parents or legal guardians.
✕Probably not a fit
Patients who do not have a diagnosis of acute otitis media or are outside the age range of 6 months to 17 years may not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This study aims to improve care for children with acute otitis media (ear infections) by comparing two interventions designed to reduce unnecessary antibiotic prescriptions. One intervention is a 'gold standard' health system approach that includes clinician education and electronic medical record tools, while the other adds a shared decision-making component to enhance parent involvement in care decisions. The study will evaluate the effectiveness of these interventions in increasing parent satisfaction and aligning care with national guidelines. By addressing the over-prescription of antibiotics, the study seeks to improve pediatric health outcomes and reduce the risk of antibiotic resistance.
Why it matters
Potential benefit: If successful, this study could lead to a significant reduction in unnecessary antibiotic prescriptions for children, improving their overall health and quality of life.
How similar studies have gone: Previous studies have shown success with similar interventions, particularly in reducing antibiotic use through watchful waiting strategies.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: A. Implementation of Interventions 1. Clinic at a participating organization 2. Provides care to children with AOM 3. Administrative or local approval for participation B. Secondary Electronic Health Record Data 1. Aged 6 months-17-years-old (inclusive) 2. Diagnosis of AOM by ICD10 code C. Video recordings or direct observation of the use of a shared decision aid Parent participation: 1. Child aged 6 months-17 years (inclusive) 2. Diagnosed with AOM by clinician 3. Parent or legal guardian is present and is \>=18 years or older Clinician Participation: 1. Licensed clinician and not a medical trainee 2. Age 18 \>= years or older D. Pre-implementation interviews of clinicians and administrators 1. Licensed clinician (physician or advanced practice clinician) that cares for children with AOM at a participating organization or an administrator/manager at a participating organization. 2. Aged \>=18 years-no maximum E. Pre-implementation focus groups of parents 1. Parent or legal guardian of a child aged 6 months-17 years (inclusive) that has had AOM diagnosed at a participating organization. 2. 18 years of age or older and able/willing to consent F. Parents enrolled for surveys 1\. Parent or legal guardian of a child aged 6 months-17 years (inclusive) that has had AOM diagnosed at a participating organization. 2. Willing to participate and able to complete electronic surveys at enrollment and 10 days after enrollment. 3. Working phone 4. Age \>=18 years of age G. Post-intervention focus groups of parents 1. Parent or legal guardian of a child aged 6 months-17 years (inclusive) that has had AOM diagnosed at a participating organization. 2. 18 years of age or older and able/willing to consent H. Post-intervention surveys of clinicians and administrators 1. Licensed clinician (physician or advanced practice clinician) that cares for children with AOM at a participating organization or an administrator/manager at a participating organization. 2. Aged \>=18 years-no maximum Exclusion Criteria: A. Implementation of Interventions 1\. Clinics that exclusively provide telehealth B. Secondary Electronic Health Record Data 1\. None C. Video recordings or direct observation of the use of a shared decision aid Parent participation: 1\. None Clinician Participation: 1\. None D. Pre-implementation interviews of clinicians and administrators 1. Medical trainee (student, resident, fellow, etc.) E. Pre-implementation focus groups of parents 1\. None F. Parents enrolled for surveys 1. Complicated or recurrent AOM as determined by the study team G. Post-intervention focus groups of parents 1. None H. Post-intervention surveys of clinicians and administrators 1\. Medical trainee (student, resident, fellow, etc.)
Where it's running
-
Denver Health and Hospital Authority
Denver, Colorado, United States Recruiting -
AllianceChicago
Chicago, Illinois, United States Recruiting -
Intermountain Health
Murray, Utah, United States Recruiting
Study contacts
- Principal investigator: Holly Frost, MD — Intermountain Health
- Study coordinator: Theresa L Morin, MA
- Email: theresa.morin@imail.org
- Phone: 802-881-9534
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Parent-led Digital Ear Imaging to Detect Acute Otitis Media
Parents use a digital otoscope at home and AI analyzes the images to see if a child has acute otitis media, aiming to reduce unnecessary doctor visits.
-
Evaluation of outcomes after in-office ear tube placement using the Tula System
This study is testing a new way to place ear tubes in kids aged 6 months to 17 years using local anesthesia to see how safe and effective it is.
-
One dose of intravenous antibiotics for complicated urinary tract infections in children
This study is testing if giving children with complicated urinary tract infections one dose of intravenous antibiotics followed by two days of oral antibiotics works just as well as the usual three doses of intravenous antibiotics.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.